institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

  • In 2025, Iloilo City confirmed four mpox cases, with local transmission established following confirmatory tests performed by health authorities in Metro Manila.
  • The cases followed initial mpox reports since May 26 in other Philippine provinces and coincide with rising infections and 198 confirmed cases this year in Spain.
  • Local authorities quarantined close contacts with no symptoms by June 17, and the city plans to conduct mpox testing locally to reduce diagnostic delays.
  • The health official in charge of Iloilo City’s response stated that although an outbreak has not been declared, the situation is being treated with utmost seriousness and called on the community to support ongoing health initiatives.
  • The situation reflects ongoing mpox spread that requires early detection, isolation, vaccination of high-risk groups, and strengthened public health coordination.
Insights by Ground AI
Does this summary seem wrong?

94 Articles

All
Left
13
Center
20
Right
7
Daily JournalDaily Journal
+52 Reposted by 52 other sources
Center

Sierra Leone seeks help for growing mpox outbreak

Sierra Leonean authorities have called for international help to curb the spread of mpox in the country as a new toll on Saturday showed the number of cases continuing to rise.

·Cherokee County, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

barlamantoday.com broke the news in on Monday, March 10, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.